Cancer clinical trials in the region Provence-Alpes-Côte d'Azur
212 currently recruiting clinical trials
If you are a doctor and would like find matching clinical trials for you patients, create an account or log in
If you are a patient and would like to know if you may participate in a clinical trial, please consult your doctor so that he can send your file to a matching trial
Early Access
Lung cancer
NSCLC (Non-Small Cell Lung Cancer)
Locally Advanced
Metastatic
EGFR
Targeted therapy
Systemic Treatment-Naive
Janssen
Early Access
Lung cancer
NSCLC (Non-Small Cell Lung Cancer)
Locally Advanced
Metastatic
EGFR
None
Systemic Treatment-Naive
Janssen
Early Access
Lung cancer
NSCLC (Non-Small Cell Lung Cancer)
Non-squamous NSCLC
Locally Advanced
EGFR
None
Chemotherapy
Radiotherapy
AstraZeneca
Early Access
Lung cancer
NSCLC (Non-Small Cell Lung Cancer)
Localized
PDL1 Positive (1% <= X < 25%)
PDL1 Positive (25% <= X < 50%)
PDL1 Positive (>= 50%)
None
Systemic Treatment-Naive
ALK
EGFR
Bristol-Myers Squibb
Early Access
Lung cancer
SCLC (Small Cell Lung Cancer)
Localized
Locally Advanced
None
Chemotherapy
Radiotherapy
Chemotherapy
Radiotherapy
AstraZeneca
Phase 3
Lung cancer
#NCT06635824
NSCLC (Non-Small Cell Lung Cancer)
Metastatic
PDL1 Positive (1% <= X < 25%)
PDL1 Positive (25% <= X < 50%)
PDL1 Positive (>= 50%)
1
2
Immunotherapy
Chemotherapy
ALK
BRAF
EGFR
KRAS G12C
KRAS non G12C
MET
RET
ROS-1
Systemic Treatment-Naive
Car-T
Hôpital Sainte Musse (Toulon), Hôpital de la Timone AP-HM (Marseille), Institut Sainte Catherine (Avignon)
Genmab
Phase 3
Lung cancer
#NCT05555732
NSCLC (Non-Small Cell Lung Cancer)
Non-squamous NSCLC
Locally Advanced
Metastatic
PDL1 Negative (< 1%)
PDL1 Positive (1% <= X < 25%)
PDL1 Positive (25% <= X < 50%)
None
Systemic Treatment-Naive
Immunotherapy
Bispecific T-cell engager antibodies
Antibody Drug Conjugates (ADC)
Immunotherapy
Bispecific T-cell engager antibodies
Antibody Drug Conjugates (ADC)
Hôpital Nord de Marseille (Marseille Cedex 20), Institut Paoli-Calmettes (Marseille), Institut Sainte Catherine (Avignon)
Daiichi Sankyo
Phase 3
Bladder / Urinary Tract / Urethral cancer
#NCT05024773
Non-invasive bladder cancer
Urothelial carcinoma
Localized
1
Immunotherapy
Systemic Treatment-Naive
Systemic Treatment-Naive
Institut Paoli-Calmettes (Marseille)
Fidia Farmaceutici s.p.a.
Phase 3
Bladder / Urinary Tract / Urethral cancer
#NCT05911295
Invasive bladder cancer
Upper excretory tract cancer
Urethral cancer
Urothelial carcinoma
Locally Advanced
Metastatic
HER2
None
Systemic Treatment-Naive
Immunotherapy
Institut Paoli-Calmettes (Marseille), Centre Antoine Lacassagne (Nice)
Seagen
Phase 3
Lymphoma
CLL & Richter's syndrome
#NCT06428019
B cell lymphoma
CLL (Chronic Lymphocytic Leukemia)
Lymphocytic lymphoma
> 60 ml/min
50-60 ml/min
30-50 ml/min
Systemic Treatment-Naive
Centre Antoine Lacassagne (Nice)
Abbvie